Identification of the missing pluripotency mediator downstream of leukaemia inhibitory factor

Graziano Martello1, Paul Bertone, Austin Smith

  • 1Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

The EMBO Journal
|August 15, 2013
PubMed

Insights

Leukaemia inhibitory factor (LIF) sustains mouse embryonic stem cell self-renewal via Stat3. Tfcp2l1 acts as the key transcription factor, bridging LIF signaling to pluripotency maintenance.

Area of Science:

  • Stem cell biology
  • Molecular genetics
  • Epigenetics

Background:

  • Pluripotent mouse embryonic stem (ES) cells require leukaemia inhibitory factor (LIF) for self-renewal, mediated by the transcription factor Stat3.
  • While Stat3 targets like Klf4 are known, they don't fully explain LIF's potent effects.

Purpose of the Study:

  • To identify the key transcription factors mediating LIF's role in ES cell self-renewal.
  • To elucidate the molecular mechanism linking LIF/Stat3 signaling to pluripotency.

Main Methods:

  • Comparative transcriptome analysis of Stat3 null ES cells.
  • Genome location data integration to identify transcription factor targets.
  • Tfcp2l1 expression manipulation (constitutive expression and knockdown).

Main Results:

  • Tfcp2l1 was identified as the most abundant candidate transcription factor effector.
  • Constitutive Tfcp2l1 expression mimicked LIF/Stat3 in sustaining self-renewal and pluripotency.
  • Tfcp2l1 knockdown abolished LIF responsiveness.
  • Tfcp2l1 was necessary and sufficient for reprogramming epiblast stem cells to naïve pluripotency.

Conclusions:

  • Tfcp2l1 is the principal transcription factor linking LIF/Stat3 signaling to the core machinery of naïve pluripotency.
  • Tfcp2l1 is a critical regulator of stem cell self-renewal and reprogramming.